HSBC Holdings’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66K | Buy |
72,248
+51,288
| +245% | +$46.8K | ﹤0.01% | 2436 |
|
|
2025
Q1 | $9.84K | Buy |
20,960
+3,572
| +21% | +$1.68K | ﹤0.01% | 2527 |
|
|
2024
Q4 | $8.75K | Sell |
17,388
-300
| -2% | -$151 | ﹤0.01% | 2629 |
|
|
2024
Q3 | $16.1K | Buy |
17,688
+2,696
| +18% | +$2.46K | ﹤0.01% | 2561 |
|
|
2024
Q2 | $14.5K | Sell |
14,992
-226
| -1% | -$219 | ﹤0.01% | 2506 |
|
|
2024
Q1 | $22.5K | Buy |
+15,218
| New | +$22.5K | ﹤0.01% | 2564 |
|
|
2017
Q1 | – | Sell |
-13,670
| Closed | -$43K | – | 1897 |
|
|
2016
Q4 | $43K | Buy |
+13,670
| New | +$43K | ﹤0.01% | 2221 |
|